Amgen Warns Against Conflating Oncology And Inflammation Biosimilars

As Biosimilar Sales Track To $2bn

 
• By Dean Rudge
  
Red Umbrella Among Black Umbrellas
Amgen has underlined the distinction between oncology and inflammation. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products